Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Treasury Shares (2021 - 2025)

Neuroone Medical Technologies (NMTC) has disclosed Treasury Shares for 5 consecutive years, with $4085.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Treasury Shares fell 67.23% year-over-year to $4085.0, compared with a TTM value of $4085.0 through Dec 2025, down 67.23%, and an annual FY2025 reading of $114968.0, up 57.25% over the prior year.
  • Treasury Shares was $4085.0 for Q4 2025 at Neuroone Medical Technologies, down from $114968.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $414430.0 in Q3 2022 and bottomed at $4.08 in Q2 2025.
  • Average Treasury Shares over 5 years is $89591.9, with a median of $26776.0 recorded in 2024.
  • The sharpest move saw Treasury Shares soared 3540.46% in 2022, then crashed 99.99% in 2025.
  • Year by year, Treasury Shares stood at $11384.0 in 2021, then skyrocketed by 3540.46% to $414430.0 in 2022, then crashed by 97.3% to $11176.0 in 2023, then increased by 11.55% to $12467.0 in 2024, then crashed by 67.23% to $4085.0 in 2025.
  • Business Quant data shows Treasury Shares for NMTC at $4085.0 in Q4 2025, $114968.0 in Q3 2025, and $4.08 in Q2 2025.